Zukunft der antiviralen Therapie der chronischen Hepatitis C. Direkt antiviral wirksame Medikamente [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
| Data(s) |
2011
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_2AA9932705A0 isbn:1615-1003 (Electronic) pmid:21194084 doi:10.1002/pauz.201100401 |
| Idioma(s) |
de |
| Fonte |
Pharmazie in unserer Zeit, vol. 40, no. 1, pp. 60-67 |
| Palavras-Chave | #Antiviral Agents/adverse effects; Antiviral Agents/therapeutic use; Clinical Trials, Phase II as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis C, Chronic/drug therapy; Humans; Interferon-alpha/adverse effects; Interferon-alpha/therapeutic use; Oligopeptides/adverse effects; Oligopeptides/therapeutic use; Proline/adverse effects; Proline/analogs & derivatives; Protease Inhibitors/therapeutic use; Viral Nonstructural Proteins/antagonists & inhibitors; Virus Replication/drug effects |
| Tipo |
info:eu-repo/semantics/review article |
